Men's health

Терапия със стволови клетки за Мъжко безплодие: разход, доказателства и как да изберете клиника

Male infertility arises from impaired spermatogenesis (low count, motility, or morphology), obstructive azoospermia, ejaculatory dysfunction, or testicular tissue damage — often multifactorial in aetiology.

Как се изучава терапия със стволови клетки за Мъжко безплодие

Male infertility arises from impaired spermatogenesis (low count, motility, or morphology), obstructive azoospermia, ejaculatory dysfunction, or testicular tissue damage — often multifactorial in aetiology. Stem-cell research investigates whether placental mesenchymal stem cells and fetal stem cells can regenerate spermatogenic epithelium, restore Sertoli- and Leydig-cell function, and promote testicular tissue recovery after chemotherapy, trauma, or infection. With 15 registered trials and 3 currently recruiting, the therapeutic scope is narrower than systemic conditions but biologically compelling: testicular microenvironment regeneration could restore fertility. Early preclinical and clinical data suggest potential for improving semen parameters, increasing testosterone production, and potentially recovering spermatogenesis in select azoospermic men.

Мъжко безплодие: терапия със стволови клетки на пръв поглед (2026)
Индикативна цена · България (ЕС)€3,000–€8,000
Глобален диапазон на пазарната цена€7,000–€25,000 (dvcstem.com)
Основни видове клетки, които се изучаватMSCs from Amniotic Membrane, Fetal Stem Cells
Статус на одобрениеЕкспериментален
Регистрирани проучвания (ClinicalTrials.gov)15 · 3 recruiting now

For the clinic's own description, see how Stem Plus describes its Male Infertility programme ↗.

Статус на одобрение — Експериментален: За Male Infertility терапия със стволови клетки не е одобрено лекарство в ЕС или САЩ — предлага се като индивидуална експериментална програма. Първо проверете дали регистриран клиничен опит е отворен за вас.

Какво показват доказателствата за Мъжко безплодие

Male infertility trials are the smallest cohort among studied conditions, reflecting disease prevalence and therapeutic complexity. Three actively recruiting studies indicate emerging clinical interest. Published data predominantly come from small preclinical and early-phase clinical series. Some trials documented improvements in semen parameters (sperm concentration, motility, morphology) following MSC infusion into testicular tissue; a few azoospermic patients recovered some spermatogenesis permitting natural conception or assisted reproduction. Testosterone levels increased in responsive cohorts, suggesting Leydig-cell regeneration. However, study heterogeneity, small sample sizes, and limited controls restrict conclusions. Mechanism studies support germ-cell niche regeneration, but direct in-vivo confirmation in humans remains incomplete. Long-term paternity outcomes are inadequately documented.

Clinical-trial reality check (Jun 2026, ClinicalTrials.gov): 15 registered stem-cell trials for Male Infertility (3 recruiting now). A registered trial is usually monitored and sometimes free — worth checking before you pay for a private programme. Browse trials ↗

Видове клетки, използвани за Мъжко безплодие

Depending on assessment, a Male Infertility protocol may draw on:

Цена на програма Мъжко безплодие

Male infertility stem-cell treatment costs typically range €4,000–7,500 per cycle, reflecting the need for testicular biopsy-guided injection or tissue regeneration protocols. Placental MSCs and fetal stem cells incur manufacturing costs; cell dose is often higher than systemic conditions due to target-tissue penetration challenges. Single-infusion protocols predominate, though repeat treatments may be considered 3–6 months after initial therapy if improvement is partial. Sperm cryopreservation and ongoing semen-parameter testing add €500–1,500 to total cost. European andrology centres (Germany, Spain, Italy, Poland) typically charge €4,000–6,000; private boutique fertility clinics may exceed €7,500. Coordination with reproductive medicine may add additional consultation costs.

Indicative EU treatment cost is €3,000–€8,000 versus roughly €15,000–35,000 in the US or Germany. Build your real all-in total with the cost calculator, see the Male Infertility cost-by-country breakdown, or compare the best countries for Male Infertility →

Преценяте ли всички си възможности за Мъжко безплодие? See the full Male Infertility treatment-options comparison — standard care, alternatives and where stem-cell therapy fits, side by side.

Before booking, check safety & regulation, the recovery climate, дали бихте могли да бъдете кандидат, and which cell type fits Male Infertility.

Въпроси, които хората задават за Мъжко безплодие

Пълен Мъжко безплодие ЧЗВ → · Разбор на разходите Мъжко безплодие →

Източници и допълнително четене

We link primary regulators, registries and peer-reviewed research so you can verify everything yourself — plus the treating clinic's own materials.

Useful tools & guides: Съм ли кандидат? · Какъв тип клетки? · Types of clinics & best countries · Калкулатор на разходи

Медицински преглед от редакционния екип на StemCellAtlas с Dr Dmytro Stoyanov (Urologist · 31+ yrs clinical practice) на партньорската клиника Stem Plus (София), спрямо ISSCR, FDA и EMA указания. Educational information, not medical advice; figures indicative.

Клетъчна терапия на европейско ниво — без европейските цени.

GMP-сертифицирана регенеративна медицина в сърцето на ЕС — от 3 000–8 000 €, част от цените в САЩ или Германия. Персонализирани протоколи за пациенти от над 50 държави.

Безплатна медицинска оценка